BioSpecifics Technologies Corp Stock News

BioSpecifics Technologies (NASDAQ:BSTC) was downgraded by ValuEngine from a “hold” rating to a “sell” rating in a research note issued to investors on Wednesday, ValuEngine reports. A number o

Citigroup Inc. grew its position in shares of BioSpecifics Technologies Corp. (NASDAQ:BSTC) by 65.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Com

BioSpecifics Technologies (NASDAQ:BSTC) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a research note issued on Tuesday, BidAskClub reports. Separately, Zacks Investment

2 key valuation ratios suggest potential bargains Continue reading...

These Stocks Are Potentially Undervalued, Stocks: BSTC,JBT,PAGS, release date:Mar 30, 2020

AQR Capital Management LLC decreased its position in BioSpecifics Technologies Corp. (NASDAQ:BSTC) by 3.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the

Shares of BioSpecifics Technologies Corp. (NASDAQ:BSTC) have earned a consensus broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports.

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Be

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 23.) Arcutis Biotherapeutics...

Unfortunately for some shareholders, the BioSpecifics Technologies (NASDAQ:BSTC) share price has dived 32% in the last...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ...

BioSpecifics Technologies (NASDAQ:BSTC) was downgraded by stock analysts at BidaskClub from a “buy” rating to a “hold” rating in a report issued on Wednesday, BidAskClub reports. A number of o

BioSpecifics Technologies Corp. (NASDAQ:BSTC) shares shot up 6% during trading on Tuesday following a better than expected earnings announcement. The company traded as high as $50.15 and last traded a

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Biospecifics Technologies (BSTC) today and set a price target of $90.00. The company's